nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—ALB—hematologic cancer	0.103	1	CbGaD
Rufinamide—CES1—Irinotecan—hematologic cancer	0.0776	0.18	CbGbCtD
Rufinamide—CYP2E1—Thalidomide—hematologic cancer	0.0287	0.0668	CbGbCtD
Rufinamide—CYP2E1—Dacarbazine—hematologic cancer	0.0247	0.0575	CbGbCtD
Rufinamide—ALB—Imatinib—hematologic cancer	0.0234	0.0543	CbGbCtD
Rufinamide—CYP2E1—Mitoxantrone—hematologic cancer	0.0192	0.0446	CbGbCtD
Rufinamide—CYP3A4—Bexarotene—hematologic cancer	0.0163	0.0379	CbGbCtD
Rufinamide—ALB—Prednisone—hematologic cancer	0.0154	0.0358	CbGbCtD
Rufinamide—CYP3A4—Lomustine—hematologic cancer	0.0152	0.0353	CbGbCtD
Rufinamide—CYP3A4—Busulfan—hematologic cancer	0.0152	0.0353	CbGbCtD
Rufinamide—ALB—Irinotecan—hematologic cancer	0.0146	0.0339	CbGbCtD
Rufinamide—CYP3A4—Thiotepa—hematologic cancer	0.0135	0.0314	CbGbCtD
Rufinamide—CYP2E1—Etoposide—hematologic cancer	0.0121	0.0281	CbGbCtD
Rufinamide—CYP3A4—Methoxsalen—hematologic cancer	0.0105	0.0244	CbGbCtD
Rufinamide—CYP3A4—Bortezomib—hematologic cancer	0.01	0.0232	CbGbCtD
Rufinamide—CYP2E1—Dexamethasone—hematologic cancer	0.00994	0.0231	CbGbCtD
Rufinamide—CYP3A4—Daunorubicin—hematologic cancer	0.00956	0.0222	CbGbCtD
Rufinamide—CYP3A4—Cytarabine—hematologic cancer	0.00843	0.0196	CbGbCtD
Rufinamide—CYP3A4—Teniposide—hematologic cancer	0.00831	0.0193	CbGbCtD
Rufinamide—ALB—Methotrexate—hematologic cancer	0.00772	0.018	CbGbCtD
Rufinamide—CYP3A4—Ifosfamide—hematologic cancer	0.00767	0.0178	CbGbCtD
Rufinamide—CYP3A4—Imatinib—hematologic cancer	0.00732	0.017	CbGbCtD
Rufinamide—CYP3A4—Ruxolitinib—hematologic cancer	0.0069	0.016	CbGbCtD
Rufinamide—CYP3A4—Nilotinib—hematologic cancer	0.00666	0.0155	CbGbCtD
Rufinamide—CYP3A4—Vinorelbine—hematologic cancer	0.0066	0.0153	CbGbCtD
Rufinamide—CYP3A4—Triamcinolone—hematologic cancer	0.00604	0.014	CbGbCtD
Rufinamide—CYP3A4—Dasatinib—hematologic cancer	0.00588	0.0137	CbGbCtD
Rufinamide—CYP3A4—Mitoxantrone—hematologic cancer	0.00581	0.0135	CbGbCtD
Rufinamide—GRM5—hematopoietic system—hematologic cancer	0.00535	0.103	CbGeAlD
Rufinamide—CYP3A4—Betamethasone—hematologic cancer	0.00518	0.012	CbGbCtD
Rufinamide—CYP3A4—Prednisolone—hematologic cancer	0.00511	0.0119	CbGbCtD
Rufinamide—CYP3A4—Prednisone—hematologic cancer	0.00483	0.0112	CbGbCtD
Rufinamide—CYP3A4—Irinotecan—hematologic cancer	0.00457	0.0106	CbGbCtD
Rufinamide—CYP3A4—Vinblastine—hematologic cancer	0.00407	0.00946	CbGbCtD
Rufinamide—CYP3A4—Vincristine—hematologic cancer	0.004	0.0093	CbGbCtD
Rufinamide—CYP3A4—Etoposide—hematologic cancer	0.00366	0.00852	CbGbCtD
Rufinamide—GRM5—blood—hematologic cancer	0.00354	0.0679	CbGeAlD
Rufinamide—CYP3A4—Dexamethasone—hematologic cancer	0.00301	0.00701	CbGbCtD
Rufinamide—GRM5—testis—hematologic cancer	0.00293	0.0562	CbGeAlD
Rufinamide—CYP3A4—Doxorubicin—hematologic cancer	0.0025	0.00581	CbGbCtD
Rufinamide—CES1—hematopoietic system—hematologic cancer	0.00211	0.0404	CbGeAlD
Rufinamide—SCN2A—hematopoietic system—hematologic cancer	0.00209	0.04	CbGeAlD
Rufinamide—SCN10A—hematopoietic system—hematologic cancer	0.00201	0.0386	CbGeAlD
Rufinamide—SCN7A—lung—hematologic cancer	0.00196	0.0376	CbGeAlD
Rufinamide—SCN7A—testis—hematologic cancer	0.00185	0.0355	CbGeAlD
Rufinamide—SCN8A—testis—hematologic cancer	0.00165	0.0316	CbGeAlD
Rufinamide—SCN9A—lung—hematologic cancer	0.00154	0.0295	CbGeAlD
Rufinamide—SCN9A—testis—hematologic cancer	0.00145	0.0278	CbGeAlD
Rufinamide—CES1—blood—hematologic cancer	0.0014	0.0268	CbGeAlD
Rufinamide—SCN2A—blood—hematologic cancer	0.00138	0.0265	CbGeAlD
Rufinamide—SCN7A—lymph node—hematologic cancer	0.00134	0.0257	CbGeAlD
Rufinamide—SCN10A—blood—hematologic cancer	0.00133	0.0256	CbGeAlD
Rufinamide—SCN1A—lung—hematologic cancer	0.00132	0.0253	CbGeAlD
Rufinamide—SCN4A—testis—hematologic cancer	0.00129	0.0248	CbGeAlD
Rufinamide—CES1—lung—hematologic cancer	0.00122	0.0235	CbGeAlD
Rufinamide—SCN3A—blood—hematologic cancer	0.00122	0.0233	CbGeAlD
Rufinamide—SCN5A—blood—hematologic cancer	0.00121	0.0232	CbGeAlD
Rufinamide—SCN3A—bone marrow—hematologic cancer	0.00118	0.0226	CbGeAlD
Rufinamide—SCN10A—lung—hematologic cancer	0.00117	0.0224	CbGeAlD
Rufinamide—CES1—testis—hematologic cancer	0.00115	0.0221	CbGeAlD
Rufinamide—SCN3A—lung—hematologic cancer	0.00107	0.0204	CbGeAlD
Rufinamide—SCN9A—lymph node—hematologic cancer	0.00105	0.0201	CbGeAlD
Rufinamide—SCN3A—testis—hematologic cancer	0.00101	0.0193	CbGeAlD
Rufinamide—CYP2E1—hematopoietic system—hematologic cancer	0.000867	0.0166	CbGeAlD
Rufinamide—CES1—lymph node—hematologic cancer	0.000837	0.0161	CbGeAlD
Rufinamide—ALB—testis—hematologic cancer	0.000803	0.0154	CbGeAlD
Rufinamide—SCN10A—lymph node—hematologic cancer	0.0008	0.0153	CbGeAlD
Rufinamide—SCN3A—lymph node—hematologic cancer	0.000729	0.014	CbGeAlD
Rufinamide—CYP3A4—hematopoietic system—hematologic cancer	0.000697	0.0134	CbGeAlD
Rufinamide—ALB—lymph node—hematologic cancer	0.000582	0.0112	CbGeAlD
Rufinamide—CYP2E1—blood—hematologic cancer	0.000574	0.011	CbGeAlD
Rufinamide—CYP2E1—lung—hematologic cancer	0.000503	0.00965	CbGeAlD
Rufinamide—CYP2E1—testis—hematologic cancer	0.000475	0.00911	CbGeAlD
Rufinamide—CYP3A4—blood—hematologic cancer	0.000462	0.00886	CbGeAlD
Rufinamide—Dizziness—Vincristine—hematologic cancer	6.14e-05	0.000217	CcSEcCtD
Rufinamide—Rash—Carmustine—hematologic cancer	6.13e-05	0.000217	CcSEcCtD
Rufinamide—Dermatitis—Carmustine—hematologic cancer	6.13e-05	0.000217	CcSEcCtD
Rufinamide—Vomiting—Alitretinoin—hematologic cancer	6.13e-05	0.000217	CcSEcCtD
Rufinamide—Infestation NOS—Doxorubicin—hematologic cancer	6.12e-05	0.000217	CcSEcCtD
Rufinamide—Infestation—Doxorubicin—hematologic cancer	6.12e-05	0.000217	CcSEcCtD
Rufinamide—Anaemia—Prednisone—hematologic cancer	6.11e-05	0.000216	CcSEcCtD
Rufinamide—Headache—Carmustine—hematologic cancer	6.1e-05	0.000216	CcSEcCtD
Rufinamide—Rash—Alitretinoin—hematologic cancer	6.08e-05	0.000215	CcSEcCtD
Rufinamide—Nervous system disorder—Betamethasone—hematologic cancer	6.07e-05	0.000215	CcSEcCtD
Rufinamide—Nervous system disorder—Dexamethasone—hematologic cancer	6.07e-05	0.000215	CcSEcCtD
Rufinamide—Agitation—Prednisone—hematologic cancer	6.07e-05	0.000215	CcSEcCtD
Rufinamide—Dermatitis—Alitretinoin—hematologic cancer	6.07e-05	0.000215	CcSEcCtD
Rufinamide—Thrombocytopenia—Dexamethasone—hematologic cancer	6.06e-05	0.000215	CcSEcCtD
Rufinamide—Thrombocytopenia—Betamethasone—hematologic cancer	6.06e-05	0.000215	CcSEcCtD
Rufinamide—Vomiting—Ifosfamide—hematologic cancer	6.06e-05	0.000214	CcSEcCtD
Rufinamide—Hypersensitivity—Cisplatin—hematologic cancer	6.05e-05	0.000214	CcSEcCtD
Rufinamide—Headache—Alitretinoin—hematologic cancer	6.04e-05	0.000214	CcSEcCtD
Rufinamide—Diarrhoea—Gemcitabine—hematologic cancer	6.03e-05	0.000213	CcSEcCtD
Rufinamide—Nausea—Thalidomide—hematologic cancer	6.02e-05	0.000213	CcSEcCtD
Rufinamide—Dyspepsia—Triamcinolone—hematologic cancer	6.01e-05	0.000213	CcSEcCtD
Rufinamide—Rash—Ifosfamide—hematologic cancer	6.01e-05	0.000213	CcSEcCtD
Rufinamide—Dermatitis—Ifosfamide—hematologic cancer	6e-05	0.000212	CcSEcCtD
Rufinamide—Dizziness—Irinotecan—hematologic cancer	5.98e-05	0.000212	CcSEcCtD
Rufinamide—Rhinitis—Epirubicin—hematologic cancer	5.95e-05	0.000211	CcSEcCtD
Rufinamide—Vertigo—Prednisone—hematologic cancer	5.94e-05	0.00021	CcSEcCtD
Rufinamide—Eye disorder—Methotrexate—hematologic cancer	5.93e-05	0.00021	CcSEcCtD
Rufinamide—Vomiting—Vincristine—hematologic cancer	5.91e-05	0.000209	CcSEcCtD
Rufinamide—Anorexia—Dexamethasone—hematologic cancer	5.9e-05	0.000209	CcSEcCtD
Rufinamide—Anorexia—Betamethasone—hematologic cancer	5.9e-05	0.000209	CcSEcCtD
Rufinamide—Asthenia—Cisplatin—hematologic cancer	5.89e-05	0.000209	CcSEcCtD
Rufinamide—Cardiac disorder—Methotrexate—hematologic cancer	5.89e-05	0.000208	CcSEcCtD
Rufinamide—Fatigue—Triamcinolone—hematologic cancer	5.88e-05	0.000208	CcSEcCtD
Rufinamide—Urinary tract disorder—Epirubicin—hematologic cancer	5.86e-05	0.000207	CcSEcCtD
Rufinamide—Rash—Vincristine—hematologic cancer	5.86e-05	0.000207	CcSEcCtD
Rufinamide—Dermatitis—Vincristine—hematologic cancer	5.85e-05	0.000207	CcSEcCtD
Rufinamide—Haematuria—Doxorubicin—hematologic cancer	5.83e-05	0.000206	CcSEcCtD
Rufinamide—Urethral disorder—Epirubicin—hematologic cancer	5.82e-05	0.000206	CcSEcCtD
Rufinamide—Headache—Vincristine—hematologic cancer	5.82e-05	0.000206	CcSEcCtD
Rufinamide—Hepatobiliary disease—Doxorubicin—hematologic cancer	5.79e-05	0.000205	CcSEcCtD
Rufinamide—Nausea—Carmustine—hematologic cancer	5.78e-05	0.000205	CcSEcCtD
Rufinamide—Epistaxis—Doxorubicin—hematologic cancer	5.77e-05	0.000204	CcSEcCtD
Rufinamide—Vomiting—Irinotecan—hematologic cancer	5.75e-05	0.000204	CcSEcCtD
Rufinamide—Vomiting—Mitoxantrone—hematologic cancer	5.75e-05	0.000204	CcSEcCtD
Rufinamide—Sinusitis—Doxorubicin—hematologic cancer	5.74e-05	0.000203	CcSEcCtD
Rufinamide—Immune system disorder—Methotrexate—hematologic cancer	5.73e-05	0.000203	CcSEcCtD
Rufinamide—Nausea—Alitretinoin—hematologic cancer	5.73e-05	0.000203	CcSEcCtD
Rufinamide—Convulsion—Prednisone—hematologic cancer	5.73e-05	0.000203	CcSEcCtD
Rufinamide—Mediastinal disorder—Methotrexate—hematologic cancer	5.72e-05	0.000202	CcSEcCtD
Rufinamide—Rash—Mitoxantrone—hematologic cancer	5.7e-05	0.000202	CcSEcCtD
Rufinamide—Rash—Irinotecan—hematologic cancer	5.7e-05	0.000202	CcSEcCtD
Rufinamide—Dermatitis—Mitoxantrone—hematologic cancer	5.7e-05	0.000202	CcSEcCtD
Rufinamide—Dermatitis—Irinotecan—hematologic cancer	5.7e-05	0.000202	CcSEcCtD
Rufinamide—Headache—Mitoxantrone—hematologic cancer	5.67e-05	0.000201	CcSEcCtD
Rufinamide—Headache—Irinotecan—hematologic cancer	5.67e-05	0.000201	CcSEcCtD
Rufinamide—Nausea—Ifosfamide—hematologic cancer	5.66e-05	0.0002	CcSEcCtD
Rufinamide—Diarrhoea—Cisplatin—hematologic cancer	5.62e-05	0.000199	CcSEcCtD
Rufinamide—Anxiety—Prednisone—hematologic cancer	5.61e-05	0.000198	CcSEcCtD
Rufinamide—Vomiting—Gemcitabine—hematologic cancer	5.6e-05	0.000198	CcSEcCtD
Rufinamide—Insomnia—Dexamethasone—hematologic cancer	5.6e-05	0.000198	CcSEcCtD
Rufinamide—Insomnia—Betamethasone—hematologic cancer	5.6e-05	0.000198	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	5.59e-05	0.000198	CcSEcCtD
Rufinamide—Mental disorder—Methotrexate—hematologic cancer	5.56e-05	0.000197	CcSEcCtD
Rufinamide—Rash—Gemcitabine—hematologic cancer	5.56e-05	0.000197	CcSEcCtD
Rufinamide—Dermatitis—Gemcitabine—hematologic cancer	5.55e-05	0.000196	CcSEcCtD
Rufinamide—Eye disorder—Epirubicin—hematologic cancer	5.55e-05	0.000196	CcSEcCtD
Rufinamide—Hypersensitivity—Etoposide—hematologic cancer	5.54e-05	0.000196	CcSEcCtD
Rufinamide—Malnutrition—Methotrexate—hematologic cancer	5.52e-05	0.000195	CcSEcCtD
Rufinamide—Headache—Gemcitabine—hematologic cancer	5.52e-05	0.000195	CcSEcCtD
Rufinamide—Nausea—Vincristine—hematologic cancer	5.52e-05	0.000195	CcSEcCtD
Rufinamide—Cardiac disorder—Epirubicin—hematologic cancer	5.51e-05	0.000195	CcSEcCtD
Rufinamide—Rhinitis—Doxorubicin—hematologic cancer	5.51e-05	0.000195	CcSEcCtD
Rufinamide—Hypersensitivity—Prednisolone—hematologic cancer	5.47e-05	0.000193	CcSEcCtD
Rufinamide—Dyspepsia—Dexamethasone—hematologic cancer	5.45e-05	0.000193	CcSEcCtD
Rufinamide—Dyspepsia—Betamethasone—hematologic cancer	5.45e-05	0.000193	CcSEcCtD
Rufinamide—Urinary tract disorder—Doxorubicin—hematologic cancer	5.42e-05	0.000192	CcSEcCtD
Rufinamide—Asthenia—Etoposide—hematologic cancer	5.4e-05	0.000191	CcSEcCtD
Rufinamide—Urethral disorder—Doxorubicin—hematologic cancer	5.38e-05	0.000191	CcSEcCtD
Rufinamide—Decreased appetite—Betamethasone—hematologic cancer	5.38e-05	0.00019	CcSEcCtD
Rufinamide—Decreased appetite—Dexamethasone—hematologic cancer	5.38e-05	0.00019	CcSEcCtD
Rufinamide—Nausea—Irinotecan—hematologic cancer	5.37e-05	0.00019	CcSEcCtD
Rufinamide—Nausea—Mitoxantrone—hematologic cancer	5.37e-05	0.00019	CcSEcCtD
Rufinamide—Immune system disorder—Epirubicin—hematologic cancer	5.36e-05	0.00019	CcSEcCtD
Rufinamide—Infection—Prednisone—hematologic cancer	5.36e-05	0.00019	CcSEcCtD
Rufinamide—Mediastinal disorder—Epirubicin—hematologic cancer	5.35e-05	0.000189	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.35e-05	0.000189	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.35e-05	0.000189	CcSEcCtD
Rufinamide—Back pain—Methotrexate—hematologic cancer	5.34e-05	0.000189	CcSEcCtD
Rufinamide—Fatigue—Dexamethasone—hematologic cancer	5.34e-05	0.000189	CcSEcCtD
Rufinamide—Fatigue—Betamethasone—hematologic cancer	5.34e-05	0.000189	CcSEcCtD
Rufinamide—Pruritus—Etoposide—hematologic cancer	5.32e-05	0.000188	CcSEcCtD
Rufinamide—Nervous system disorder—Prednisone—hematologic cancer	5.29e-05	0.000187	CcSEcCtD
Rufinamide—Skin disorder—Prednisone—hematologic cancer	5.24e-05	0.000185	CcSEcCtD
Rufinamide—Nausea—Gemcitabine—hematologic cancer	5.23e-05	0.000185	CcSEcCtD
Rufinamide—Vomiting—Cisplatin—hematologic cancer	5.22e-05	0.000185	CcSEcCtD
Rufinamide—Vision blurred—Methotrexate—hematologic cancer	5.2e-05	0.000184	CcSEcCtD
Rufinamide—Mental disorder—Epirubicin—hematologic cancer	5.2e-05	0.000184	CcSEcCtD
Rufinamide—Rash—Cisplatin—hematologic cancer	5.18e-05	0.000183	CcSEcCtD
Rufinamide—Dermatitis—Cisplatin—hematologic cancer	5.17e-05	0.000183	CcSEcCtD
Rufinamide—Malnutrition—Epirubicin—hematologic cancer	5.17e-05	0.000183	CcSEcCtD
Rufinamide—Diarrhoea—Etoposide—hematologic cancer	5.15e-05	0.000182	CcSEcCtD
Rufinamide—Anorexia—Prednisone—hematologic cancer	5.14e-05	0.000182	CcSEcCtD
Rufinamide—Eye disorder—Doxorubicin—hematologic cancer	5.13e-05	0.000182	CcSEcCtD
Rufinamide—Anaemia—Methotrexate—hematologic cancer	5.1e-05	0.000181	CcSEcCtD
Rufinamide—Cardiac disorder—Doxorubicin—hematologic cancer	5.1e-05	0.00018	CcSEcCtD
Rufinamide—Hypersensitivity—Triamcinolone—hematologic cancer	5.03e-05	0.000178	CcSEcCtD
Rufinamide—Back pain—Epirubicin—hematologic cancer	5e-05	0.000177	CcSEcCtD
Rufinamide—Dizziness—Etoposide—hematologic cancer	4.98e-05	0.000176	CcSEcCtD
Rufinamide—Immune system disorder—Doxorubicin—hematologic cancer	4.96e-05	0.000176	CcSEcCtD
Rufinamide—Vertigo—Methotrexate—hematologic cancer	4.96e-05	0.000176	CcSEcCtD
Rufinamide—Mediastinal disorder—Doxorubicin—hematologic cancer	4.95e-05	0.000175	CcSEcCtD
Rufinamide—Leukopenia—Methotrexate—hematologic cancer	4.94e-05	0.000175	CcSEcCtD
Rufinamide—Dizziness—Prednisolone—hematologic cancer	4.91e-05	0.000174	CcSEcCtD
Rufinamide—Asthenia—Triamcinolone—hematologic cancer	4.9e-05	0.000173	CcSEcCtD
Rufinamide—Nausea—Cisplatin—hematologic cancer	4.88e-05	0.000173	CcSEcCtD
Rufinamide—Insomnia—Prednisone—hematologic cancer	4.88e-05	0.000173	CcSEcCtD
Rufinamide—Vision blurred—Epirubicin—hematologic cancer	4.87e-05	0.000172	CcSEcCtD
Rufinamide—Pruritus—Triamcinolone—hematologic cancer	4.83e-05	0.000171	CcSEcCtD
Rufinamide—Mental disorder—Doxorubicin—hematologic cancer	4.81e-05	0.00017	CcSEcCtD
Rufinamide—Convulsion—Methotrexate—hematologic cancer	4.78e-05	0.000169	CcSEcCtD
Rufinamide—Vomiting—Etoposide—hematologic cancer	4.78e-05	0.000169	CcSEcCtD
Rufinamide—Malnutrition—Doxorubicin—hematologic cancer	4.78e-05	0.000169	CcSEcCtD
Rufinamide—Anaemia—Epirubicin—hematologic cancer	4.78e-05	0.000169	CcSEcCtD
Rufinamide—Agitation—Epirubicin—hematologic cancer	4.75e-05	0.000168	CcSEcCtD
Rufinamide—Dyspepsia—Prednisone—hematologic cancer	4.75e-05	0.000168	CcSEcCtD
Rufinamide—Rash—Etoposide—hematologic cancer	4.74e-05	0.000168	CcSEcCtD
Rufinamide—Dermatitis—Etoposide—hematologic cancer	4.74e-05	0.000168	CcSEcCtD
Rufinamide—Headache—Etoposide—hematologic cancer	4.71e-05	0.000167	CcSEcCtD
Rufinamide—Decreased appetite—Prednisone—hematologic cancer	4.69e-05	0.000166	CcSEcCtD
Rufinamide—Rash—Prednisolone—hematologic cancer	4.68e-05	0.000166	CcSEcCtD
Rufinamide—Dermatitis—Prednisolone—hematologic cancer	4.67e-05	0.000165	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.67e-05	0.000165	CcSEcCtD
Rufinamide—Fatigue—Prednisone—hematologic cancer	4.65e-05	0.000165	CcSEcCtD
Rufinamide—Headache—Prednisolone—hematologic cancer	4.65e-05	0.000165	CcSEcCtD
Rufinamide—Vertigo—Epirubicin—hematologic cancer	4.64e-05	0.000164	CcSEcCtD
Rufinamide—Leukopenia—Epirubicin—hematologic cancer	4.63e-05	0.000164	CcSEcCtD
Rufinamide—Back pain—Doxorubicin—hematologic cancer	4.63e-05	0.000164	CcSEcCtD
Rufinamide—Constipation—Prednisone—hematologic cancer	4.61e-05	0.000163	CcSEcCtD
Rufinamide—Dizziness—Triamcinolone—hematologic cancer	4.51e-05	0.00016	CcSEcCtD
Rufinamide—Vision blurred—Doxorubicin—hematologic cancer	4.51e-05	0.000159	CcSEcCtD
Rufinamide—Convulsion—Epirubicin—hematologic cancer	4.48e-05	0.000158	CcSEcCtD
Rufinamide—Infection—Methotrexate—hematologic cancer	4.48e-05	0.000158	CcSEcCtD
Rufinamide—Nausea—Etoposide—hematologic cancer	4.47e-05	0.000158	CcSEcCtD
Rufinamide—Asthenia—Betamethasone—hematologic cancer	4.44e-05	0.000157	CcSEcCtD
Rufinamide—Asthenia—Dexamethasone—hematologic cancer	4.44e-05	0.000157	CcSEcCtD
Rufinamide—Nervous system disorder—Methotrexate—hematologic cancer	4.42e-05	0.000156	CcSEcCtD
Rufinamide—Anaemia—Doxorubicin—hematologic cancer	4.42e-05	0.000156	CcSEcCtD
Rufinamide—Thrombocytopenia—Methotrexate—hematologic cancer	4.41e-05	0.000156	CcSEcCtD
Rufinamide—Nausea—Prednisolone—hematologic cancer	4.41e-05	0.000156	CcSEcCtD
Rufinamide—Agitation—Doxorubicin—hematologic cancer	4.39e-05	0.000156	CcSEcCtD
Rufinamide—Anxiety—Epirubicin—hematologic cancer	4.38e-05	0.000155	CcSEcCtD
Rufinamide—Pruritus—Dexamethasone—hematologic cancer	4.38e-05	0.000155	CcSEcCtD
Rufinamide—Pruritus—Betamethasone—hematologic cancer	4.38e-05	0.000155	CcSEcCtD
Rufinamide—Skin disorder—Methotrexate—hematologic cancer	4.38e-05	0.000155	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.37e-05	0.000155	CcSEcCtD
Rufinamide—Vomiting—Triamcinolone—hematologic cancer	4.34e-05	0.000154	CcSEcCtD
Rufinamide—Rash—Triamcinolone—hematologic cancer	4.3e-05	0.000152	CcSEcCtD
Rufinamide—Dermatitis—Triamcinolone—hematologic cancer	4.3e-05	0.000152	CcSEcCtD
Rufinamide—Vertigo—Doxorubicin—hematologic cancer	4.3e-05	0.000152	CcSEcCtD
Rufinamide—Anorexia—Methotrexate—hematologic cancer	4.3e-05	0.000152	CcSEcCtD
Rufinamide—Leukopenia—Doxorubicin—hematologic cancer	4.28e-05	0.000151	CcSEcCtD
Rufinamide—Headache—Triamcinolone—hematologic cancer	4.28e-05	0.000151	CcSEcCtD
Rufinamide—Diarrhoea—Betamethasone—hematologic cancer	4.24e-05	0.00015	CcSEcCtD
Rufinamide—Diarrhoea—Dexamethasone—hematologic cancer	4.24e-05	0.00015	CcSEcCtD
Rufinamide—Infection—Epirubicin—hematologic cancer	4.19e-05	0.000148	CcSEcCtD
Rufinamide—Convulsion—Doxorubicin—hematologic cancer	4.14e-05	0.000147	CcSEcCtD
Rufinamide—Nervous system disorder—Epirubicin—hematologic cancer	4.14e-05	0.000146	CcSEcCtD
Rufinamide—Thrombocytopenia—Epirubicin—hematologic cancer	4.13e-05	0.000146	CcSEcCtD
Rufinamide—Skin disorder—Epirubicin—hematologic cancer	4.1e-05	0.000145	CcSEcCtD
Rufinamide—Dizziness—Betamethasone—hematologic cancer	4.09e-05	0.000145	CcSEcCtD
Rufinamide—Dizziness—Dexamethasone—hematologic cancer	4.09e-05	0.000145	CcSEcCtD
Rufinamide—Insomnia—Methotrexate—hematologic cancer	4.08e-05	0.000144	CcSEcCtD
Rufinamide—Anxiety—Doxorubicin—hematologic cancer	4.06e-05	0.000144	CcSEcCtD
Rufinamide—Nausea—Triamcinolone—hematologic cancer	4.05e-05	0.000143	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.04e-05	0.000143	CcSEcCtD
Rufinamide—Anorexia—Epirubicin—hematologic cancer	4.02e-05	0.000142	CcSEcCtD
Rufinamide—Somnolence—Methotrexate—hematologic cancer	4.01e-05	0.000142	CcSEcCtD
Rufinamide—Hypersensitivity—Prednisone—hematologic cancer	3.97e-05	0.000141	CcSEcCtD
Rufinamide—Dyspepsia—Methotrexate—hematologic cancer	3.97e-05	0.00014	CcSEcCtD
Rufinamide—Vomiting—Betamethasone—hematologic cancer	3.94e-05	0.000139	CcSEcCtD
Rufinamide—Vomiting—Dexamethasone—hematologic cancer	3.94e-05	0.000139	CcSEcCtD
Rufinamide—Decreased appetite—Methotrexate—hematologic cancer	3.92e-05	0.000139	CcSEcCtD
Rufinamide—Rash—Dexamethasone—hematologic cancer	3.9e-05	0.000138	CcSEcCtD
Rufinamide—Rash—Betamethasone—hematologic cancer	3.9e-05	0.000138	CcSEcCtD
Rufinamide—Dermatitis—Betamethasone—hematologic cancer	3.9e-05	0.000138	CcSEcCtD
Rufinamide—Dermatitis—Dexamethasone—hematologic cancer	3.9e-05	0.000138	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.89e-05	0.000138	CcSEcCtD
Rufinamide—Fatigue—Methotrexate—hematologic cancer	3.89e-05	0.000138	CcSEcCtD
Rufinamide—Headache—Betamethasone—hematologic cancer	3.88e-05	0.000137	CcSEcCtD
Rufinamide—Headache—Dexamethasone—hematologic cancer	3.88e-05	0.000137	CcSEcCtD
Rufinamide—Infection—Doxorubicin—hematologic cancer	3.88e-05	0.000137	CcSEcCtD
Rufinamide—Asthenia—Prednisone—hematologic cancer	3.87e-05	0.000137	CcSEcCtD
Rufinamide—Nervous system disorder—Doxorubicin—hematologic cancer	3.83e-05	0.000135	CcSEcCtD
Rufinamide—Thrombocytopenia—Doxorubicin—hematologic cancer	3.82e-05	0.000135	CcSEcCtD
Rufinamide—Pruritus—Prednisone—hematologic cancer	3.82e-05	0.000135	CcSEcCtD
Rufinamide—Insomnia—Epirubicin—hematologic cancer	3.81e-05	0.000135	CcSEcCtD
Rufinamide—Skin disorder—Doxorubicin—hematologic cancer	3.79e-05	0.000134	CcSEcCtD
Rufinamide—Somnolence—Epirubicin—hematologic cancer	3.75e-05	0.000133	CcSEcCtD
Rufinamide—Anorexia—Doxorubicin—hematologic cancer	3.72e-05	0.000132	CcSEcCtD
Rufinamide—Dyspepsia—Epirubicin—hematologic cancer	3.71e-05	0.000131	CcSEcCtD
Rufinamide—Diarrhoea—Prednisone—hematologic cancer	3.69e-05	0.000131	CcSEcCtD
Rufinamide—Nausea—Betamethasone—hematologic cancer	3.68e-05	0.00013	CcSEcCtD
Rufinamide—Nausea—Dexamethasone—hematologic cancer	3.68e-05	0.00013	CcSEcCtD
Rufinamide—Decreased appetite—Epirubicin—hematologic cancer	3.67e-05	0.00013	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.64e-05	0.000129	CcSEcCtD
Rufinamide—Fatigue—Epirubicin—hematologic cancer	3.64e-05	0.000129	CcSEcCtD
Rufinamide—Constipation—Epirubicin—hematologic cancer	3.61e-05	0.000128	CcSEcCtD
Rufinamide—Dizziness—Prednisone—hematologic cancer	3.57e-05	0.000126	CcSEcCtD
Rufinamide—Insomnia—Doxorubicin—hematologic cancer	3.53e-05	0.000125	CcSEcCtD
Rufinamide—Somnolence—Doxorubicin—hematologic cancer	3.47e-05	0.000123	CcSEcCtD
Rufinamide—Dyspepsia—Doxorubicin—hematologic cancer	3.44e-05	0.000122	CcSEcCtD
Rufinamide—Vomiting—Prednisone—hematologic cancer	3.43e-05	0.000121	CcSEcCtD
Rufinamide—Rash—Prednisone—hematologic cancer	3.4e-05	0.00012	CcSEcCtD
Rufinamide—Dermatitis—Prednisone—hematologic cancer	3.4e-05	0.00012	CcSEcCtD
Rufinamide—Decreased appetite—Doxorubicin—hematologic cancer	3.39e-05	0.00012	CcSEcCtD
Rufinamide—Headache—Prednisone—hematologic cancer	3.38e-05	0.00012	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.37e-05	0.000119	CcSEcCtD
Rufinamide—Fatigue—Doxorubicin—hematologic cancer	3.36e-05	0.000119	CcSEcCtD
Rufinamide—Constipation—Doxorubicin—hematologic cancer	3.34e-05	0.000118	CcSEcCtD
Rufinamide—Hypersensitivity—Methotrexate—hematologic cancer	3.32e-05	0.000118	CcSEcCtD
Rufinamide—Asthenia—Methotrexate—hematologic cancer	3.23e-05	0.000114	CcSEcCtD
Rufinamide—Nausea—Prednisone—hematologic cancer	3.2e-05	0.000113	CcSEcCtD
Rufinamide—Pruritus—Methotrexate—hematologic cancer	3.19e-05	0.000113	CcSEcCtD
Rufinamide—Hypersensitivity—Epirubicin—hematologic cancer	3.11e-05	0.00011	CcSEcCtD
Rufinamide—Diarrhoea—Methotrexate—hematologic cancer	3.08e-05	0.000109	CcSEcCtD
Rufinamide—Asthenia—Epirubicin—hematologic cancer	3.03e-05	0.000107	CcSEcCtD
Rufinamide—Pruritus—Epirubicin—hematologic cancer	2.98e-05	0.000106	CcSEcCtD
Rufinamide—Dizziness—Methotrexate—hematologic cancer	2.98e-05	0.000105	CcSEcCtD
Rufinamide—Diarrhoea—Epirubicin—hematologic cancer	2.89e-05	0.000102	CcSEcCtD
Rufinamide—Hypersensitivity—Doxorubicin—hematologic cancer	2.88e-05	0.000102	CcSEcCtD
Rufinamide—Vomiting—Methotrexate—hematologic cancer	2.87e-05	0.000101	CcSEcCtD
Rufinamide—Rash—Methotrexate—hematologic cancer	2.84e-05	0.000101	CcSEcCtD
Rufinamide—Dermatitis—Methotrexate—hematologic cancer	2.84e-05	0.0001	CcSEcCtD
Rufinamide—Headache—Methotrexate—hematologic cancer	2.82e-05	9.99e-05	CcSEcCtD
Rufinamide—Asthenia—Doxorubicin—hematologic cancer	2.8e-05	9.91e-05	CcSEcCtD
Rufinamide—Dizziness—Epirubicin—hematologic cancer	2.79e-05	9.87e-05	CcSEcCtD
Rufinamide—Pruritus—Doxorubicin—hematologic cancer	2.76e-05	9.77e-05	CcSEcCtD
Rufinamide—Vomiting—Epirubicin—hematologic cancer	2.68e-05	9.49e-05	CcSEcCtD
Rufinamide—Nausea—Methotrexate—hematologic cancer	2.68e-05	9.47e-05	CcSEcCtD
Rufinamide—Diarrhoea—Doxorubicin—hematologic cancer	2.67e-05	9.45e-05	CcSEcCtD
Rufinamide—Rash—Epirubicin—hematologic cancer	2.66e-05	9.41e-05	CcSEcCtD
Rufinamide—Dermatitis—Epirubicin—hematologic cancer	2.66e-05	9.4e-05	CcSEcCtD
Rufinamide—Headache—Epirubicin—hematologic cancer	2.64e-05	9.35e-05	CcSEcCtD
Rufinamide—Dizziness—Doxorubicin—hematologic cancer	2.58e-05	9.13e-05	CcSEcCtD
Rufinamide—Nausea—Epirubicin—hematologic cancer	2.51e-05	8.87e-05	CcSEcCtD
Rufinamide—Vomiting—Doxorubicin—hematologic cancer	2.48e-05	8.78e-05	CcSEcCtD
Rufinamide—Rash—Doxorubicin—hematologic cancer	2.46e-05	8.71e-05	CcSEcCtD
Rufinamide—Dermatitis—Doxorubicin—hematologic cancer	2.46e-05	8.7e-05	CcSEcCtD
Rufinamide—Headache—Doxorubicin—hematologic cancer	2.44e-05	8.65e-05	CcSEcCtD
Rufinamide—Nausea—Doxorubicin—hematologic cancer	2.32e-05	8.2e-05	CcSEcCtD
Rufinamide—GRM5—Signaling Pathways—CCND1—hematologic cancer	1.3e-05	9.89e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—JUN—hematologic cancer	1.3e-05	9.87e-05	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—IL6—hematologic cancer	1.3e-05	9.84e-05	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—HRAS—hematologic cancer	1.29e-05	9.75e-05	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—HRAS—hematologic cancer	1.29e-05	9.75e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—SRC—hematologic cancer	1.29e-05	9.74e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—RASGRP1—hematologic cancer	1.28e-05	9.73e-05	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—AKT1—hematologic cancer	1.28e-05	9.72e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SYK—hematologic cancer	1.28e-05	9.7e-05	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—IL6—hematologic cancer	1.28e-05	9.68e-05	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—IL6—hematologic cancer	1.28e-05	9.68e-05	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—HRAS—hematologic cancer	1.27e-05	9.61e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CDKN1A—hematologic cancer	1.26e-05	9.56e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—FHL2—hematologic cancer	1.26e-05	9.55e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTEN—hematologic cancer	1.26e-05	9.54e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—VEGFA—hematologic cancer	1.25e-05	9.49e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	1.25e-05	9.45e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—STAT3—hematologic cancer	1.24e-05	9.39e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NRAS—hematologic cancer	1.24e-05	9.37e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AGRN—hematologic cancer	1.24e-05	9.37e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MAPK8—hematologic cancer	1.23e-05	9.33e-05	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—IL6—hematologic cancer	1.23e-05	9.33e-05	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—IL6—hematologic cancer	1.23e-05	9.33e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—AKT1—hematologic cancer	1.23e-05	9.31e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IFNA2—hematologic cancer	1.23e-05	9.3e-05	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—AKT1—hematologic cancer	1.23e-05	9.29e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTAP—hematologic cancer	1.22e-05	9.21e-05	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—IL6—hematologic cancer	1.21e-05	9.19e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	1.21e-05	9.19e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EP300—hematologic cancer	1.2e-05	9.1e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MAPK3—hematologic cancer	1.18e-05	8.97e-05	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—AKT1—hematologic cancer	1.18e-05	8.93e-05	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—AKT1—hematologic cancer	1.18e-05	8.93e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HMMR—hematologic cancer	1.17e-05	8.88e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—IDH2—hematologic cancer	1.17e-05	8.88e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SRC—hematologic cancer	1.17e-05	8.85e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—GRB2—hematologic cancer	1.15e-05	8.75e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PDGFA—hematologic cancer	1.15e-05	8.73e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	1.15e-05	8.72e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TGFB1—hematologic cancer	1.15e-05	8.71e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VEGFA—hematologic cancer	1.14e-05	8.62e-05	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—AKT1—hematologic cancer	1.14e-05	8.61e-05	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—AKT1—hematologic cancer	1.14e-05	8.61e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—STAT3—hematologic cancer	1.13e-05	8.53e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NRAS—hematologic cancer	1.12e-05	8.51e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.11e-05	8.45e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PHYH—hematologic cancer	1.11e-05	8.44e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—FTCD—hematologic cancer	1.11e-05	8.44e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GMPS—hematologic cancer	1.11e-05	8.44e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—ABL1—hematologic cancer	1.11e-05	8.41e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ARNTL—hematologic cancer	1.1e-05	8.35e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—FHL2—hematologic cancer	1.08e-05	8.21e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MAPK3—hematologic cancer	1.08e-05	8.15e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TNF—hematologic cancer	1.07e-05	8.13e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CA9—hematologic cancer	1.07e-05	8.12e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ACP5—hematologic cancer	1.07e-05	8.12e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—KRAS—hematologic cancer	1.06e-05	8.07e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AGRN—hematologic cancer	1.06e-05	8.05e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NCOR2—hematologic cancer	1.06e-05	8.02e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IL2—hematologic cancer	1.06e-05	8.01e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MYC—hematologic cancer	1.05e-05	7.93e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TGFB1—hematologic cancer	1.04e-05	7.91e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HGF—hematologic cancer	1.04e-05	7.9e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CSF2—hematologic cancer	1.03e-05	7.82e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.02e-05	7.72e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—IDH1—hematologic cancer	1.01e-05	7.64e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HMMR—hematologic cancer	1.01e-05	7.63e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—IDH2—hematologic cancer	1.01e-05	7.63e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TXN—hematologic cancer	9.96e-06	7.55e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCC3—hematologic cancer	9.96e-06	7.55e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTO1—hematologic cancer	9.96e-06	7.55e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—JAK1—hematologic cancer	9.96e-06	7.54e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PRKCG—hematologic cancer	9.96e-06	7.54e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SPHK1—hematologic cancer	9.75e-06	7.39e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KRAS—hematologic cancer	9.67e-06	7.33e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.5e-06	7.2e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ARNTL—hematologic cancer	9.47e-06	7.17e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—UGT1A1—hematologic cancer	9.37e-06	7.1e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	9.3e-06	7.05e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IL2RA—hematologic cancer	9.3e-06	7.05e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	9.23e-06	6.99e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CA9—hematologic cancer	9.21e-06	6.98e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ACP5—hematologic cancer	9.21e-06	6.98e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC22A1—hematologic cancer	9.11e-06	6.91e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CRABP1—hematologic cancer	9.11e-06	6.91e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NCOR2—hematologic cancer	9.09e-06	6.89e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—HRAS—hematologic cancer	9.05e-06	6.86e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	8.99e-06	6.81e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PDGFB—hematologic cancer	8.97e-06	6.8e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—B3GAT1—hematologic cancer	8.9e-06	6.74e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—DCK—hematologic cancer	8.9e-06	6.74e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ASNS—hematologic cancer	8.9e-06	6.74e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CA—hematologic cancer	8.88e-06	6.73e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALOX5—hematologic cancer	8.88e-06	6.73e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CDK2—hematologic cancer	8.71e-06	6.6e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—IDH1—hematologic cancer	8.66e-06	6.56e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—IL6—hematologic cancer	8.66e-06	6.56e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NUP98—hematologic cancer	8.6e-06	6.52e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—hematologic cancer	8.59e-06	6.51e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TXN—hematologic cancer	8.56e-06	6.49e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTO1—hematologic cancer	8.56e-06	6.49e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCC3—hematologic cancer	8.56e-06	6.49e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	8.5e-06	6.44e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HDC—hematologic cancer	8.44e-06	6.39e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SPHK1—hematologic cancer	8.38e-06	6.35e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MAPK14—hematologic cancer	8.35e-06	6.33e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ADCY7—hematologic cancer	8.35e-06	6.33e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NCOA3—hematologic cancer	8.35e-06	6.33e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NUP214—hematologic cancer	8.29e-06	6.28e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	8.25e-06	6.25e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HRAS—hematologic cancer	8.22e-06	6.23e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCG2—hematologic cancer	8.12e-06	6.15e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MTR—hematologic cancer	8.12e-06	6.15e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—FN1—hematologic cancer	8.09e-06	6.13e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—UGT1A1—hematologic cancer	8.05e-06	6.1e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—AKT1—hematologic cancer	7.99e-06	6.05e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ENO2—hematologic cancer	7.97e-06	6.04e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL6—hematologic cancer	7.87e-06	5.96e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC22A1—hematologic cancer	7.83e-06	5.93e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CRABP1—hematologic cancer	7.83e-06	5.93e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CG—hematologic cancer	7.75e-06	5.87e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTT1—hematologic cancer	7.73e-06	5.85e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CDA—hematologic cancer	7.72e-06	5.85e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ALOX5—hematologic cancer	7.63e-06	5.78e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PTPN11—hematologic cancer	7.61e-06	5.77e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SDC1—hematologic cancer	7.55e-06	5.72e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PC—hematologic cancer	7.43e-06	5.63e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NUP98—hematologic cancer	7.39e-06	5.6e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AKT1—hematologic cancer	7.26e-06	5.5e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CREBBP—hematologic cancer	7.18e-06	5.44e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ADCY7—hematologic cancer	7.18e-06	5.44e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NCOA3—hematologic cancer	7.18e-06	5.44e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GBA—hematologic cancer	7.17e-06	5.44e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC35B2—hematologic cancer	7.17e-06	5.44e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NUP214—hematologic cancer	7.13e-06	5.4e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.05e-06	5.34e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	7.02e-06	5.32e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTR—hematologic cancer	6.98e-06	5.29e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCG2—hematologic cancer	6.98e-06	5.29e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ENO2—hematologic cancer	6.85e-06	5.19e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CD—hematologic cancer	6.81e-06	5.16e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTT1—hematologic cancer	6.64e-06	5.03e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTAP—hematologic cancer	6.56e-06	4.97e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.54e-06	4.95e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SDC1—hematologic cancer	6.49e-06	4.92e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3R1—hematologic cancer	6.43e-06	4.87e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CD44—hematologic cancer	6.42e-06	4.87e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NQO1—hematologic cancer	6.42e-06	4.87e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—JAK2—hematologic cancer	6.25e-06	4.74e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.22e-06	4.71e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.2e-06	4.7e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYCS—hematologic cancer	6.08e-06	4.6e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	6.04e-06	4.57e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CB—hematologic cancer	5.94e-06	4.5e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.85e-06	4.44e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—FHL2—hematologic cancer	5.85e-06	4.43e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AGRN—hematologic cancer	5.74e-06	4.35e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	5.73e-06	4.34e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CD44—hematologic cancer	5.52e-06	4.18e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NQO1—hematologic cancer	5.52e-06	4.18e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IL2—hematologic cancer	5.45e-06	4.13e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—IDH2—hematologic cancer	5.44e-06	4.12e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HMMR—hematologic cancer	5.44e-06	4.12e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.4e-06	4.09e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTP1—hematologic cancer	5.36e-06	4.06e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYCS—hematologic cancer	5.22e-06	3.96e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HSP90AA1—hematologic cancer	5.19e-06	3.93e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.11e-06	3.87e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCB1—hematologic cancer	5.07e-06	3.84e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CA9—hematologic cancer	4.97e-06	3.77e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ACP5—hematologic cancer	4.97e-06	3.77e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTM1—hematologic cancer	4.92e-06	3.73e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NCOR1—hematologic cancer	4.92e-06	3.73e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.91e-06	3.72e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—EP300—hematologic cancer	4.89e-06	3.71e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SRC—hematologic cancer	4.76e-06	3.6e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—IDH1—hematologic cancer	4.68e-06	3.54e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.67e-06	3.54e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—hematologic cancer	4.63e-06	3.51e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.62e-06	3.5e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.62e-06	3.5e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TXN—hematologic cancer	4.62e-06	3.5e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTP1—hematologic cancer	4.6e-06	3.49e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NRAS—hematologic cancer	4.58e-06	3.47e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.52e-06	3.43e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.45e-06	3.37e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MAPK3—hematologic cancer	4.38e-06	3.32e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCB1—hematologic cancer	4.36e-06	3.3e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MTHFR—hematologic cancer	4.35e-06	3.3e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.35e-06	3.29e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TGFB1—hematologic cancer	4.25e-06	3.22e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTM1—hematologic cancer	4.23e-06	3.2e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NCOR1—hematologic cancer	4.23e-06	3.2e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.23e-06	3.2e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.23e-06	3.2e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.12e-06	3.12e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NUP98—hematologic cancer	3.99e-06	3.02e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—KRAS—hematologic cancer	3.94e-06	2.98e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.87e-06	2.94e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.87e-06	2.94e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NUP214—hematologic cancer	3.85e-06	2.91e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.77e-06	2.86e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTR—hematologic cancer	3.77e-06	2.86e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTHFR—hematologic cancer	3.74e-06	2.83e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ENO2—hematologic cancer	3.7e-06	2.8e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CG—hematologic cancer	3.65e-06	2.77e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CA—hematologic cancer	3.62e-06	2.74e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.58e-06	2.72e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SDC1—hematologic cancer	3.5e-06	2.65e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—hematologic cancer	3.5e-06	2.65e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CREBBP—hematologic cancer	3.39e-06	2.57e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HRAS—hematologic cancer	3.35e-06	2.54e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.29e-06	2.5e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CD—hematologic cancer	3.21e-06	2.43e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALB—hematologic cancer	3.17e-06	2.4e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CG—hematologic cancer	3.14e-06	2.38e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3R1—hematologic cancer	3.03e-06	2.3e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CD44—hematologic cancer	2.98e-06	2.26e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NQO1—hematologic cancer	2.98e-06	2.26e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT1—hematologic cancer	2.96e-06	2.24e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CREBBP—hematologic cancer	2.91e-06	2.21e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYCS—hematologic cancer	2.82e-06	2.14e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.8e-06	2.12e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CB—hematologic cancer	2.8e-06	2.12e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CD—hematologic cancer	2.76e-06	2.09e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3R1—hematologic cancer	2.61e-06	1.98e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.48e-06	1.88e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTEN—hematologic cancer	2.42e-06	1.83e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CB—hematologic cancer	2.41e-06	1.82e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.35e-06	1.78e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—EP300—hematologic cancer	2.31e-06	1.75e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.28e-06	1.73e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.28e-06	1.73e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTEN—hematologic cancer	2.08e-06	1.58e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.02e-06	1.53e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—EP300—hematologic cancer	1.98e-06	1.5e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.71e-06	1.29e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.7e-06	1.28e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.57e-06	1.19e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.49e-06	1.13e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALB—hematologic cancer	1.47e-06	1.11e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CA—hematologic cancer	1.47e-06	1.11e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.41e-06	1.07e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKT1—hematologic cancer	1.39e-06	1.06e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.3e-06	9.84e-06	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKT1—hematologic cancer	1.2e-06	9.08e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTEN—hematologic cancer	1.12e-06	8.51e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—EP300—hematologic cancer	1.07e-06	8.11e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.92e-07	6e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKT1—hematologic cancer	6.47e-07	4.9e-06	CbGpPWpGaD
